Γλιβενκλαμίδη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Γλιβενκλαμίδη" in Greek language version.

refsWebsite

Global rank Greek rank

4^th place

4^th place

2^nd place

3^rd place

6^th place

5^th place

archive.org

Marble A (1971). «Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?». Drugs 1 (2): 109–15. doi:10.2165/00003495-197101020-00001. PMID 4999930. https://archive.org/details/sim_drugs_1971_2_2/page/109.
Gangji, A. S.; Cukierman, T.; Gerstein, H. C.; Goldsmith, C. H.; Clase, C. M. (1 February 2007). «A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events: A comparison of glyburide with other secretagogues and with insulin». Diabetes Care 30 (2): 389–394. doi:10.2337/dc06-1789. PMID 17259518. https://archive.org/details/sim_diabetes-care_2007-02_30_2/page/389.
«Glyburide-induced acute haemolysis in a G6PD-deficient patient with NIDDM». Br. J. Haematol. 92 (1): 159–60. January 1996. doi:10.1046/j.1365-2141.1996.275810.x. PMID 8562390. https://archive.org/details/sim_british-journal-of-haematology_1996-01_92_1/page/159.
«Glibenclamide, a blocker of K+(ATP) channels, shows antileishmanial activity in experimental murine cutaneous leishmaniasis». Antimicrob. Agents Chemother. 50 (12): 4214–6. December 2006. doi:10.1128/AAC.00617-06. PMID 17015627. PMC 1693980. https://archive.org/details/sim_antimicrobial-agents-and-chemotherapy_2006-12_50_12/page/4214.

doi.org

dx.doi.org

Marble A (1971). «Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?». Drugs 1 (2): 109–15. doi:10.2165/00003495-197101020-00001. PMID 4999930. https://archive.org/details/sim_drugs_1971_2_2/page/109.
Riddle MC (February 2003). «Editorial: sulfonylureas differ in effects on ischemic preconditioning--is it time to retire glyburide?». J. Clin. Endocrinol. Metab. 88 (2): 528–30. doi:10.1210/jc.2002-021971. PMID 12574174.
Balsells, M; García-Patterson, A; Solà, I; Roqué, M; Gich, I; Corcoy, R (21 January 2015). «Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis.». BMJ (Clinical research ed.) 350: h102. doi:10.1136/bmj.h102. PMID 25609400.
Gangji, A. S.; Cukierman, T.; Gerstein, H. C.; Goldsmith, C. H.; Clase, C. M. (1 February 2007). «A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events: A comparison of glyburide with other secretagogues and with insulin». Diabetes Care 30 (2): 389–394. doi:10.2337/dc06-1789. PMID 17259518. https://archive.org/details/sim_diabetes-care_2007-02_30_2/page/389.
«Glyburide-induced acute haemolysis in a G6PD-deficient patient with NIDDM». Br. J. Haematol. 92 (1): 159–60. January 1996. doi:10.1046/j.1365-2141.1996.275810.x. PMID 8562390. https://archive.org/details/sim_british-journal-of-haematology_1996-01_92_1/page/159.
«Three-year mortality in diabetic patients treated with different combinations of insulin secretagogues and metformin». Diabetes Metab Res Rev 22 (6): 477–82. 2006. doi:10.1002/dmrr.642. PMID 16634115.
«Glibenclamide, a blocker of K+(ATP) channels, shows antileishmanial activity in experimental murine cutaneous leishmaniasis». Antimicrob. Agents Chemother. 50 (12): 4214–6. December 2006. doi:10.1128/AAC.00617-06. PMID 17015627. PMC 1693980. https://archive.org/details/sim_antimicrobial-agents-and-chemotherapy_2006-12_50_12/page/4214.
Ahmadi, A; Khalili, M; Khatami, K; Farsadrooh, M; Nahri-Niknafs, B (2014). «Synthesis and investigating hypoglycemic and hypolipidemic activities of some glibenclamide analogues in rats». Mini reviews in medicinal chemistry 14 (2): 208–13. doi:10.2174/1570193x10666140103112311. PMID 24387708.
«Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke». Nat. Med. 12 (4): 433–40. April 2006. doi:10.1038/nm1390. PMID 16550187.

nih.gov

ncbi.nlm.nih.gov

Marble A (1971). «Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?». Drugs 1 (2): 109–15. doi:10.2165/00003495-197101020-00001. PMID 4999930. https://archive.org/details/sim_drugs_1971_2_2/page/109.
Riddle MC (February 2003). «Editorial: sulfonylureas differ in effects on ischemic preconditioning--is it time to retire glyburide?». J. Clin. Endocrinol. Metab. 88 (2): 528–30. doi:10.1210/jc.2002-021971. PMID 12574174.
Balsells, M; García-Patterson, A; Solà, I; Roqué, M; Gich, I; Corcoy, R (21 January 2015). «Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis.». BMJ (Clinical research ed.) 350: h102. doi:10.1136/bmj.h102. PMID 25609400.
Gangji, A. S.; Cukierman, T.; Gerstein, H. C.; Goldsmith, C. H.; Clase, C. M. (1 February 2007). «A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events: A comparison of glyburide with other secretagogues and with insulin». Diabetes Care 30 (2): 389–394. doi:10.2337/dc06-1789. PMID 17259518. https://archive.org/details/sim_diabetes-care_2007-02_30_2/page/389.
«Glyburide-induced acute haemolysis in a G6PD-deficient patient with NIDDM». Br. J. Haematol. 92 (1): 159–60. January 1996. doi:10.1046/j.1365-2141.1996.275810.x. PMID 8562390. https://archive.org/details/sim_british-journal-of-haematology_1996-01_92_1/page/159.
«Three-year mortality in diabetic patients treated with different combinations of insulin secretagogues and metformin». Diabetes Metab Res Rev 22 (6): 477–82. 2006. doi:10.1002/dmrr.642. PMID 16634115.
«Glibenclamide, a blocker of K+(ATP) channels, shows antileishmanial activity in experimental murine cutaneous leishmaniasis». Antimicrob. Agents Chemother. 50 (12): 4214–6. December 2006. doi:10.1128/AAC.00617-06. PMID 17015627. PMC 1693980. https://archive.org/details/sim_antimicrobial-agents-and-chemotherapy_2006-12_50_12/page/4214.
Ahmadi, A; Khalili, M; Khatami, K; Farsadrooh, M; Nahri-Niknafs, B (2014). «Synthesis and investigating hypoglycemic and hypolipidemic activities of some glibenclamide analogues in rats». Mini reviews in medicinal chemistry 14 (2): 208–13. doi:10.2174/1570193x10666140103112311. PMID 24387708.
«Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke». Nat. Med. 12 (4): 433–40. April 2006. doi:10.1038/nm1390. PMID 16550187.

pubmedcentral.nih.gov

Balsells, M; García-Patterson, A; Solà, I; Roqué, M; Gich, I; Corcoy, R (21 January 2015). «Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis.». BMJ (Clinical research ed.) 350: h102. doi:10.1136/bmj.h102. PMID 25609400.
«Glibenclamide, a blocker of K+(ATP) channels, shows antileishmanial activity in experimental murine cutaneous leishmaniasis». Antimicrob. Agents Chemother. 50 (12): 4214–6. December 2006. doi:10.1128/AAC.00617-06. PMID 17015627. PMC 1693980. https://archive.org/details/sim_antimicrobial-agents-and-chemotherapy_2006-12_50_12/page/4214.
«Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke». Nat. Med. 12 (4): 433–40. April 2006. doi:10.1038/nm1390. PMID 16550187.